Federation Des Caisses Desjardins Du Quebec Akouos, Inc. Transaction History

Federation Des Caisses Desjardins Du Quebec

  • $18.9 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Aug 14, 2024
SELL
$0.0 - $13.51 $0 - $2,837
-210 Closed
0 $0
Q1 2022

Aug 14, 2024
BUY
$4.16 - $9.08 $873 - $1,906
210 New
210 $998,000
Q2 2021

Aug 30, 2024
BUY
$11.87 - $15.96 $2,492 - $3,351
210 New
210 $2.64 Million
Q1 2021

Aug 30, 2024
BUY
$13.87 - $21.04 $2,912 - $4,418
210 New
210 $2.91 Million

About Akouos, Inc.

AKUS Quotes by TradingView
  • Ticker AKUS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,929,000
  • Description
  • Akouos, Inc., a precision genetic medicine company, developing gene therapies to restore, improve, and preserve physiologic hearing for individuals. The company's precision genetic medicine platform incorporates a proprietary adeno-associated viral vector library and a novel delivery approach. Its lead product candidate is AK-OTOF, a gene therap...
More about AKUS
Track This Portfolio

Track Federation Des Caisses Desjardins Du Quebec Portfolio

Follow Federation Des Caisses Desjardins Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email